haha
Lv4
410 积分
2023-06-14 加入
-
Shao Z, et al. SABCS 2018. Abstract P6-17-17
7个月前
已关闭
-
Expression of the HER1–4 family of receptor tyrosine kinases in breast cancer
7个月前
已完结
-
中国鼻咽癌放射治疗指南(2022版)
8个月前
已完结
-
Long-Term Outcomes of Adjuvant Denosumab in Breast Cancer
10个月前
已完结
-
Long-term outcomes of adjuvant denosumab in breast cancer: Fracture reduction and survival results from 3,425 patients in the randomised, double-blind, placebo-controlled ABCSG-18 trial
10个月前
已完结
-
Prognostic significance of HER3 in patients with malignant solid tumors
10个月前
已完结
-
Activating HER3 mutations in breast cancer
10个月前
已完结
-
A randomized, double-blind phase II trial of exemestane plus MM-121 (a monoclonal antibody targeting ErbB3) or placebo in postmenopausal women with locally advanced or metastatic ER+/PR+, HER2-negative breast cancer
11个月前
已关闭
-
A randomized, double-blind phase II trial of exemestane plus MM-121 (a monoclonal antibody targeting ErbB3) or placebo in postmenopausal women with locally advanced or metastatic ER+/PR+, HER2-negative breast cancer
11个月前
已完结
-
A randomized, double-blind phase II trial of exemestane plus MM-121 (a monoclonal antibody targeting ErbB3) or placebo in postmenopausal women with locally advanced or metastatic ER+/PR+, HER2-negative breast cancer
11个月前
已关闭